Page last updated: 2024-08-21

1-naphthylisothiocyanate and Hypercholesterolemia

1-naphthylisothiocyanate has been researched along with Hypercholesterolemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Groen, AK; Hoekstra, M; van der Geest, R; van der Sluis, RJ; Van Eck, M1
Groen, AK; Hoekstra, M; Ouweneel, AB; van der Geest, R; van der Sluis, RJ; Van Eck, M1

Other Studies

2 other study(ies) available for 1-naphthylisothiocyanate and Hypercholesterolemia

ArticleYear
Cholestasis-associated glucocorticoid overexposure does not increase atherogenesis.
    The Journal of endocrinology, 2019, Volume: 242, Issue:2

    Topics: 1-Naphthylisothiocyanate; Animals; Apolipoproteins E; Atherosclerosis; Cholestasis; Cholesterol; Corticosterone; Disease Models, Animal; Glucocorticoids; Humans; Hypercholesterolemia; Mice, Inbred C57BL; Mice, Knockout; Risk Factors; Species Specificity

2019
Endogenous glucocorticoids exacerbate cholestasis-associated liver injury and hypercholesterolemia in mice.
    Toxicology and applied pharmacology, 2016, 09-01, Volume: 306

    Topics: 1-Naphthylisothiocyanate; Adrenalectomy; Animals; Bile Acids and Salts; Cholestasis; Cholesterol; Corticosterone; Hypercholesterolemia; Liver; Liver Diseases; Mice, Inbred C57BL; Mifepristone; Receptors, Cytoplasmic and Nuclear; Receptors, Glucocorticoid

2016